Human intestinal M cells function as dendritic cell-like antigen-presenting cells, displaying constitutive MHC-II activity ...

Targeting receptors for erythropoietin on dendritic cells may be a viable strategy for treating MS and other diseases, ...

Ever notice that as you get older, some foods no longer sit with you the same? This could be due to a breakdown of the ...

Researchers uncover a key mechanism that could pave the way for novel therapies in inflammatory bowel disease (IBD). A team ...

By manipulating this pathway, scientists may be able to tweak the immune response to treat cancers, autoimmune disorders, and more.

Targeting receptors for erythropoietin on dendritic cells may be a viable strategy for treating MS and other diseases, ...

That’s just the ones who are diagnosed. Many more have undiagnosed autoimmune reactions and are the most misdiagnosed and overlooked patient population.

Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients with advanced or metastatic solid tumors, ...

Erythropoietin, the protein that drives red blood cell formation, also induces tolerance in dendritic cells, leading to the development of regulatory T cells.

A single signaling pathway controls whether immune cells attack or befriend cells they encounter while patrolling our bodies, researchers at Stanford ...

Autoimmune diseases, like multiple sclerosis result when the body's immune system starts to attack its own cells. Regulatory T cells, a subtype of T cells play a critical role in suppressing these ...